Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Effect of Aging on Tissues01:19

The Effect of Aging on Tissues

Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
Aging01:26

Aging

Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characterisation of phosphate transport in epididymis and prostate with possible relevance for semen quality.

EBioMedicine·2025
Same author

Changes in local mineral homeostasis facilitate the formation of benign and malignant testicular microcalcifications.

eLife·2025
Same author

Abaloparatide Enhances Bone Regeneration in Extraction Socket Dental Implant Defects: An Experimental In Vivo Study.

Clinical oral implants research·2025
Same author

Healing sequelae following tooth extraction and dental implant placement in an aged, ovariectomy model.

JBMR plus·2024
Same author

Comparative study in estrogen-depleted mice identifies skeletal and osteocyte transcriptomic responses to abaloparatide and teriparatide.

JCI insight·2023
Same author

Sex-Specific Differences in G<sub>s</sub>α-Mediated Signaling Downstream of PTH1R Activation by Abaloparatide in Bone.

JBMR plus·2022

Related Experiment Videos

Premature aging in klotho mutant mice: cause or consequence?

Beate Lanske1, M Shawkat Razzaque

  • 1Department of Developmental Biology, Harvard School of Dental Medicine, Research and Educational Building, 190 Longwood Avenue, Boston, MA 02115, USA. beate_lanske@hsdm.harvard.edu

Ageing Research Reviews
|March 14, 2007
PubMed
Summary

Fibroblast growth factor 23 (Fgf-23) and klotho are key regulators of aging. Klotho acts as a cofactor for Fgf-23, explaining why klotho-deficient mice exhibit premature aging phenotypes.

Related Experiment Videos

Area of Science:

  • Gerontology and Molecular Biology
  • Genetics and Developmental Biology

Background:

  • Mammalian models are crucial for studying aging mechanisms.
  • Fibroblast growth factor 23 (Fgf-23) null mice and klotho hypomorphs exhibit premature aging phenotypes.

Purpose of the Study:

  • To investigate the molecular mechanisms underlying premature aging in mouse models.
  • To elucidate the relationship between Fgf-23 and klotho in aging processes.

Main Methods:

  • Comparative analysis of Fgf-23 null mice and klotho hypomorphs.
  • Examination of in vivo phenotypes, including lifespan, fertility, and tissue pathology.
  • Biochemical and morphological assessments of aging markers.

Main Results:

  • Both Fgf-23 null mice and klotho hypomorphs display similar premature aging features.
  • Klotho acts as a necessary cofactor for Fgf-23 signaling.
  • Klotho deficiency impairs Fgf-23 bioactivity, leading to aging phenotypes.

Conclusions:

  • Premature aging in klotho-deficient mice is a consequence of impaired Fgf-23 activity.
  • Fgf-23 and klotho signaling pathways are interconnected in regulating aging.
  • Klotho's role as an aging factor is redefined through its function as an Fgf-23 cofactor.